Last reviewed · How we verify

NCT04052646

Prehospital Deaths From Spontaneous Subarachnoid Haemorrhages

Completed Last updated 13 April 2020
What this trial tests

trial testing Medical condition: Subarachnoid hemorrhage in Subarachnoid Hemorrhage in 58 participants. Completed in 31 January 2020.

Timeline
13 September 2019
Primary endpoint
31 January 2020
31 January 2020

Quick facts

Lead sponsorRigshospitalet, Denmark
StatusCompleted
Study typeOBSERVATIONAL
Enrollment58
Start date13 September 2019
Primary completion31 January 2020
Estimated completion31 January 2020
Sites1 location across Denmark

Drugs / interventions tested

Conditions studied

Sponsor

Rigshospitalet, Denmark

Who can join

Eligibility, any sex, with Subarachnoid Hemorrhage. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this study we aim to determine the incidence of fatal spontaneous subarachnoid haemorrhage outside hospital. Also, we aim to investigate these patient´s pattern of contact to the health care system immediately before their death and to describe the circumstances under which they died.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Subarachnoid Hemorrhage

Currently open trials in the same condition.

Other Rigshospitalet, Denmark trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04052646.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing